Sat, December 10, 2011
Fri, December 9, 2011
Thu, December 8, 2011
Wed, December 7, 2011
Tue, December 6, 2011
Mon, December 5, 2011
Sun, December 4, 2011
Fri, December 2, 2011
Thu, December 1, 2011
Wed, November 30, 2011
[ Wed, Nov 30th 2011 ] - Market Wire
Watson Launches Generic LIPITOR
Tue, November 29, 2011
Mon, November 28, 2011
Sun, November 27, 2011
Fri, November 25, 2011
Thu, November 24, 2011

Biodel to Report Fourth Quarter Fiscal Year 2011 Financial Results on December 6, 2011


//health-fitness.news-articles.net/content/2011/ .. r-2011-financial-results-on-december-6-2011.html
Published in Health and Fitness on Thursday, December 1st 2011 at 13:10 GMT by Market Wire   Print publication without navigation


Biodel to Report Fourth Quarter Fiscal Year 2011 Financial Results on December 6,... -- DANBURY, Conn., Dec. 1, 2011 /PRNewswire/ --

Biodel to Report Fourth Quarter Fiscal Year 2011 Financial Results on December 6, 2011

[ ]

DANBURY, Conn., Dec. 1, 2011 /PRNewswire/ -- Biodel Inc. (Nasdaq: [ BIOD ]) will issue its fourth quarter fiscal year 2011 financial results on December 6, 2011.  Following the release of the company's financial results, Biodel's senior management will host a conference call to discuss the results and provide an update on the company's progress.

 

December 6, 2011 schedule:

 

 

 

 

4:00 pm EST:

Q4 fiscal year 2011 results will be distributed

 

 

 

 

4:15 pm EST:

Conference call participants should dial:

 

 

+1 ( 877 ) 303 - 8025  (United States) or

 

 

+1 ( 760 ) 536 - 5162  (International)

 

 

 

 

4:30 pm EST:

Conference call begins

 

 

 

 

 

 

 

 

 

Interested parties may access a live audio webcast of the conference call in the investor section of Biodel's website at [ www.biodel.com ].  The audio webcast will be archived and available for replay through the website.

About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients.  We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles.  For further information regarding Biodel, please visit the company's website at [ www.biodel.com ].

BIOD-G

Contact: Seth D. Lewis, +1-646-378-2952

SOURCE Biodel Inc.

[ Back to top ]

RELATED LINKS
[ http://www.biodel.com ]


Publication Contributing Sources